MedTrace Logo

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands

NCT03583034 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 275

Last updated 2018-07-12

No results posted yet for this study

Summary

The efficacy and safety of holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) have been comprehensively assessed. However, HoLEP is considered as a challenging procedure with a steep learning curve. As such, HoLEP is not as yet considered the gold standard for the surgical treatment of LUTS/BPH by international clinical guidelines.

The investigators aim to assess the complications and outcomes of patients treated with HoLEP by high volume surgeons, in order to provide data on the safety of the procedure and identify the profile of patients who may benefit from a dedicated clinical management to reduce the risk of post-operative complications.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

Holmium laser enucleation of the prostate (HoLEP)

Surgery for benign prostatic hyperplasia

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-18
Primary Completion
2019-04-18
Completion
2020-06-18

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03583034 on ClinicalTrials.gov